Navigation Links
Maharashtra warns against Mahim's 'miracle' water

As large crowds continued to throng the Mahim beach to drink sweet seawater for the second day, the Maharashtra government Sunday warned people against drinking// the polluted water.

Scientists clarified that the seawater had turned sweet due to the natural phenomenon of dilution.

"Dilution is a phenomenon observed all along the western coast of India during the southwest monsoon and occurs when rainwater borne by rivers mixe with seawater along the coast," said M.D. Zingde, a scientist at the National Institute of Oceanography regional centre in Mumbai.

"The change in salinity at the Mahim creek could be attributed to the large quantities of groundwater draining into the sea because of the rains.

"The noticeable drop in salinity levels occurs at low tide when the maximum dilution of seawater by fresh water occurs. Apart from this, one must also consider that the Mithi river, too, flows into the Mahim creek," he added.

Weekend reports of the Mahim creek's water tasting sweet sparked a flood of visitors near the Baba Maqdoom Dargah to witness and partake the "miracle" water.

The Brihanmumbai Municipal Corporation (BMC) Saturday conducted tests to establish pollutant levels in the water and warned people against waterborne diseases from consumption.

"The water in the Mahim creek is absolutely not potable. Samples of water taken from the creek showed low chloride content, which in itself is harmful. The samples contained dangerous levels of nitrates and would affect people who consume too much of the 'sweet water'," said BMC commissioner Johnny Joseph.

"The decline in salinity was mainly due to two reasons. Apart from the Mithi river flowing into the Mahim creek, water from the sweet water Vihar Lake, too, was draining into the creek, thereby reducing the salinity," Joseph told IANS Sunday.

Infectious disease experts have warned that drinking water with an except
'"/>




Page: 1 2

Related medicine news :

1. Doctors strike called off in Maharashtra
2. HIV/AIDS Declining In Maharashtra, TN, Ktk And AP: UN Report
3. Experts Warn of Bird Flu Recurrence in Maharashtra
4. Maharashtra Medical And Dental Colleges Decide To Fix Own Fees
5. Reports Of Chikun Guniya In Few Maharashtra Districts
6. Seven Dead in Maharashtra Due to Suspected Chikungunya
7. Chikungunya Disease Hits Maharashtra
8. Polio cases in Maharashtra
9. Maharashtra Cracks Down On Fake Doctors
10. TB Incidence on Rise Among Children in Tamil Nadu, Maharashtra
11. International community warns India on HIV situation
Post Your Comments:
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 1RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 2RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 3RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 4Injection Reverses Heart Attack Damage 4771 1Injection Reverses Heart Attack Damage 4771 2Injection Reverses Heart Attack Damage 4771 3Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 1Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 2Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 3
Other Medicine Technology:Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 3Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 4Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 5Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 6Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 2Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 3Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 4Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 5Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 6